neuroblastoma, the most common extracranial solid tumor of infancy, is linked with cell proliferation and differentia-tion. Neuroblastoma can be selectively targeted via mono-clonal antibodies against the disialoganglioside (GD2) tumor-associated antigen. Liposomes coated with anti-GD2 antibodies (targeted liposomes) and entrapping a c-myb antisense oligonucleotide have antitumor activity. Because antisense oligonucleotides containing CpG motifs can stim-ulate immune responses, we evaluated the effect of CpG-containing c-myb antisense oligonucleotides encapsulated within targeted liposomes. Methods: Antisense (myb-as) and scrambled (myb-scr) control oligonucleotides with CpG mo-tifs were encapsulated within GD2-targeted and non-targeted lip...
AbstractAntisense gene therapy using molecules such as antisense oligodeoxynucleotides, siRNA or miR...
Tumor targeting by genetically modified mesenchymal stromal/stem cells (MSCs) carrying anti-cancer m...
Tumor cells are typically poorly immunogenic. The same mechanisms that evolved to avoid the inductio...
BACKGROUND:Advanced-stage neuroblastoma resists conventional treatment; hence, novel therapeutic app...
blastoma resists conventional treat-ment; hence, novel therapeutic ap-proaches are required. We eval...
Accessibility of tumors for highly effective local treatment represents a major challenge for antica...
Neuroblastoma (NB) is the most common extracranial solid tumor in children, accounting for about 8% ...
Chimeric antigen receptor (CAR)-expressing T cells are a promising therapeutic option for patients w...
Disialoganglioside GD2 is an established target for immuno-therapy in neuroblastoma. We tested the h...
Although dose intensification of chemotherapy has increased initial response rates in neuroblastoma ...
Background The ganglioside GD2 is an attractive target for immunotherapy of neuroectodermal tumors....
Immunotherapy brings new hope to the fight against lung cancer. General immunostimulatory agents rep...
Neuroblastoma is the most common extra-cranial solid tumor of childhood and it is characterized by t...
Home made liposomes incorporating chemotherapy agents are cojugated to specific antibodies and used ...
Neuroblastoma is a pediatric solid cancer of heterogeneous clinical behavior. The unique features of...
AbstractAntisense gene therapy using molecules such as antisense oligodeoxynucleotides, siRNA or miR...
Tumor targeting by genetically modified mesenchymal stromal/stem cells (MSCs) carrying anti-cancer m...
Tumor cells are typically poorly immunogenic. The same mechanisms that evolved to avoid the inductio...
BACKGROUND:Advanced-stage neuroblastoma resists conventional treatment; hence, novel therapeutic app...
blastoma resists conventional treat-ment; hence, novel therapeutic ap-proaches are required. We eval...
Accessibility of tumors for highly effective local treatment represents a major challenge for antica...
Neuroblastoma (NB) is the most common extracranial solid tumor in children, accounting for about 8% ...
Chimeric antigen receptor (CAR)-expressing T cells are a promising therapeutic option for patients w...
Disialoganglioside GD2 is an established target for immuno-therapy in neuroblastoma. We tested the h...
Although dose intensification of chemotherapy has increased initial response rates in neuroblastoma ...
Background The ganglioside GD2 is an attractive target for immunotherapy of neuroectodermal tumors....
Immunotherapy brings new hope to the fight against lung cancer. General immunostimulatory agents rep...
Neuroblastoma is the most common extra-cranial solid tumor of childhood and it is characterized by t...
Home made liposomes incorporating chemotherapy agents are cojugated to specific antibodies and used ...
Neuroblastoma is a pediatric solid cancer of heterogeneous clinical behavior. The unique features of...
AbstractAntisense gene therapy using molecules such as antisense oligodeoxynucleotides, siRNA or miR...
Tumor targeting by genetically modified mesenchymal stromal/stem cells (MSCs) carrying anti-cancer m...
Tumor cells are typically poorly immunogenic. The same mechanisms that evolved to avoid the inductio...